Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial
Letter
[키워드] 1:1
7-point ordinal scale
accelerate
activities
activity
acute respiratory syndrome
adaptive
addition
administration
Admission
airway
Akershus
allocation sequence
Analysis
anticipated
approach
automatically
baseline
Biochemistry
Biomarker
blinded
Blinding
Blood
C-reactive protein
cardiac troponin
Chloroquine
clinical
Clinical outcome
Clinical practice
clinical status
clinical symptom
collected
condition
coronavirus
coronavirus disease
COVID-19
Culture
database
Department
disease
dissemination
early treatment
element
Endpoint
examined
excluded
extracorporeal membrane oxygenation
Good
harmonization
hepatic injury
history
hospital
Hospital admission
hospitalisation
hospitalised
hospitalised patient
Hospitalized
Hydroxychloroquine
Hypothesis
In-hospital
include
independent
Inpatient
intensive care
intensive care unit
International Conference
Intervention
intervention arm
Invasive mechanical ventilation
Laboratory
marker
Microbiology
Mortality
nasopharyngeal
NEWS2
non-invasive ventilation
Norway
number
Nurse
objective
open label
Oropharyngeal
Oropharyngeal sampling
outcome
oxygen
participant
Patient
patients
peptide
Placebo
polymerase chain
polymerase chain reaction
positive
Practice
Pragmatic
pragmatic trial
primary endpoint
profile
Prolonged
Protein
protocol
QT interval
randomisation
randomised
randomised controlled
randomised controlled trial
randomization
Randomized
Randomized controlled trial
recruited
recruitment
Registered
renal
requiring supplemental oxygen
resource
responsible
RT-PCR
Safe
Sample size
SARS-CoV-2
SARS-CoV-2 viral load
score
secondary
Seven
standard care
statistical analyses
status
Study protocol
subjects
Surveillance
therapy
transcriptase
Treatment
treatment allocation
Trial
Two-arm
university
use of hydroxychloroquine
Viral load
virological clearance
viruses
vital signs
website
[DOI] 10.1186/s13063-020-04420-0 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04420-0 PMC 바로가기 [Article Type] Letter